SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM
(HKEX: 1349)
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. engages in research and development and commercialization of drugs. Its research and development platforms include genetic technical platform, photodynamic platform, nano technical platform and oral solid preparation platform. The company’s products include ALA on photodynamic technical platform, LIBOd on nano technical platform and all kinds of diagnostic reagents on diagnosis technology platform. Shanghai Fudan Zhangjiang Bio Pharmaceutical was founded by Jun Li, Hai Bo Wang and Da Jun Zhao on November 11, 1996 and is headquartered in Shanghai, China.
2.920 -
-0.010
(-0.34%)
Range
2.890 - 2.950
(2.08%)
Open
2.950
Previous Close
2.930
Bid Price
2.920
Bid Volume
('000)
65
Ask Price
2.940
Ask Volume
('000)
24
Volume
('000)
787
Value
2,298,550
Remark
-
View All Events
Loading Chart...
Please login to view stock data and analysis